SPECIAL BULLETIN COVID-19 #25: Emergency Update to NC Medicaid and NC Health Choice Preferred Drug List (PDL) and REMS Program Flexibilities

Friday, March 27, 2020

Preferred Drug List (PDL) Update

Effective March 25, 2020, due to drug shortages in the marketplace, the NC Medicaid and NC Health Choice PDL Category of “Respiratory: Beta-Adrenergic Handheld, Short Acting” has changed to the following:

Preferred Non-Preferred
albuterol HFA inhaler (generic for Proair® HFA Inhaler / Proventil® HFA Inhaler / Ventolin® HFA Inhaler) levalbuterol HFA inhaler (generic for Xopenex® HFA Inhaler)
Proair® HFA Inhaler  Proair® DigihalerTM Inhaler
Proair® RespiClick® Inhaler  
Proventil® HFA Inhaler  
Ventolin® HFA Inhaler  
Xopenex® HFA Inhaler  

Please visit the following site for a full PDL listing: https://medicaid.ncdhhs.gov/documents/preferred-drug-list 

Updated Guidance for REMS Requirements

NC Medicaid would like to share information about recent FDA guidance regarding REMS requirements during the COVID-19 public health emergency.
Please visit https://www.fda.gov/media/136317/download for the current recommendations. 

GDIT, (800) 688-6696